Becton Dickinson & Co. (BDX)

246.82
1.40 0.56
NYSE : Health Technology
Prev Close 248.22
Open 248.29
Day Low/High 244.12 / 248.81
52 Wk Low/High 208.62 / 265.87
Volume 382.33K
Avg Volume 1.43M
Exchange NYSE
Shares Outstanding 269.73M
Market Cap 67.43B
EPS 0.60
P/E Ratio 71.83
Div & Yield 3.08 (1.23%)

Latest News

BD Announces Early Tender Results

BD Announces Early Tender Results

FRANKLIN LAKES, N.J.

The Charts of Becton, Dickinson Need More 'Work' Before a Rally

The Charts of Becton, Dickinson Need More 'Work' Before a Rally

Let's check the charts and indicators.

Hold on Tight: Cramer's 'Mad Money' Recap (Monday 5/13/19)

Hold on Tight: Cramer's 'Mad Money' Recap (Monday 5/13/19)

Fasten your seatbelt, says Jim Cramer. Trade tensions are making for a wild ride on Wall Street, but stocks are almost in oversold territory.

Disney, 21st Century Fox, Village Farms: 'Mad Money' Lightning Round

Disney, 21st Century Fox, Village Farms: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Disney, 21st Century Fox, Village Farms, SailPoint Technologies, Magellan Midstream Partners, Becton Dickinson, Puma Biotechnology, Parsons and more.

BD Announces Results For 2019 Second Fiscal Quarter; Updates Fiscal 2019 Guidance

BD Announces Results For 2019 Second Fiscal Quarter; Updates Fiscal 2019 Guidance

- As reported, revenues of $4.195 billion decreased 0.6 percent.

Becton, Dickinson Expected to Earn $2.58 a Share

Becton, Dickinson Expected to Earn $2.58 a Share

Becton, Dickinson revenue expected to rise 0.4% to $4.2 billion.

BD Receives FDA Approval For Fully Sterile Chlorhexidine Gluconate Antiseptic Skin Preparation

BD Receives FDA Approval For Fully Sterile Chlorhexidine Gluconate Antiseptic Skin Preparation

New BD ChloraPrep™ Skin Preparation is the Only Commercially Available CHG Antiseptic Skin Preparation with Sterile Solution Designation in the U.S.

BD Board Declares Dividends

BD Board Declares Dividends

FRANKLIN LAKES, N.J.

BD Unveils Platelet Quality Control Media To Help Reduce The Incidence Of Sepsis In Patients Requiring Platelet Transfusion

BD Unveils Platelet Quality Control Media To Help Reduce The Incidence Of Sepsis In Patients Requiring Platelet Transfusion

BD BACTEC™ Platelet Quality Control Media is cleared by the U.S. Food and Drug Administration and CE-IVD marked for platelet testing

BD Launches New Automated Flow Cytometry Sample Preparation Instrument With CE-IVD Certification

BD Launches New Automated Flow Cytometry Sample Preparation Instrument With CE-IVD Certification

BD FACSDuet™ system raises the bar on flow cytometry automation offering a fully integrated sample-to-answer solution with the BD FACSLyric™ clinical flow cytometer

BD Statement On Paclitaxel-Coated Devices

BD Statement On Paclitaxel-Coated Devices

FRANKLIN LAKES, N.J.

BD Receives U.S. FDA Approval For First Venous Stent To Treat Iliofemoral Venous Occlusive Disease

BD Receives U.S. FDA Approval For First Venous Stent To Treat Iliofemoral Venous Occlusive Disease

Venovo™ Venous Stent proven safe and effective in iliac and femoral veins

BD To Present At The Barclays Global Healthcare Conference

BD To Present At The Barclays Global Healthcare Conference

FRANKLIN LAKES, N.J.

Becton, Dickinson Becomes #155 Most Shorted S&P 500 Component, Replacing AbbVie

Becton, Dickinson Becomes #155 Most Shorted S&P 500 Component, Replacing AbbVie

The most recent short interest data has been released for the 01/31/2019 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: APTV, ATAX, BDX, CBT, GS, IT, LXP, MHO, SF, SLGN, VOXX, WGP Downgrades: ADM, M, MWA, NVDA Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

'Do It Yourself' Stock Picking, GOOGL Opportunity, Disney Reports: Market Recon

'Do It Yourself' Stock Picking, GOOGL Opportunity, Disney Reports: Market Recon

The selloff in Alphabet presents opportunity, and I think this cash machine is ripe for a small long position.

BD Announces Results For 2019 First Fiscal Quarter; Reaffirms Fiscal 2019 Guidance

BD Announces Results For 2019 First Fiscal Quarter; Reaffirms Fiscal 2019 Guidance

- As reported, revenues of $4.160 billion increased 35.1 percent.

8 Earnings to Watch Before the Market Opens Tuesday

8 Earnings to Watch Before the Market Opens Tuesday

Viacom, BP and ADM among companies expected to report before the start of trading Tuesday.

BD Launches Ergonomic Pen Needle Technology To Help Optimize Injection Technique

BD Launches Ergonomic Pen Needle Technology To Help Optimize Injection Technique

BD Nano™ Second Generation Pen Needle Receives 510(k) Clearance from U.S. Food and Drug Administration

BD Board Declares Dividends

BD Board Declares Dividends

FRANKLIN LAKES, N.J.

Becton Dickinson Expects First-Quarter Earnings to Beat Wall Street Estimates

Becton Dickinson Expects First-Quarter Earnings to Beat Wall Street Estimates

Becton Dickinson sees 35.1% revenue growth for its fiscal first quarter.

BD Announces Preliminary Results For 2019 First Fiscal Quarter; Reaffirms Fiscal 2019 Guidance

BD Announces Preliminary Results For 2019 First Fiscal Quarter; Reaffirms Fiscal 2019 Guidance

- Preliminary reported revenues of $4.160 billion increased 35.1 percent.

BD Announces Webcast Of Annual Meeting Of Shareholders

BD Announces Webcast Of Annual Meeting Of Shareholders

FRANKLIN LAKES, N.J.

TheStreet Quant Rating: B- (Buy)